S97 Stock Chart & Stats
€16.70
-€0.10(-0.53%)
At close: 4:00 PM EDT
€16.70
-€0.10(-0.53%)
Day’s Range― - ―
52-Week Range€11.90 - €19.40
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€1.27B
Enterprise Value€2.35K
Total Cash (Recent Filing)€33.46M
Total Debt (Recent Filing)€202.59M
Price to Earnings (P/E)23.0
Beta0.33
Next Earnings
Nov 11, 2026EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.23
Shares Outstanding72,125,320
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.58
Price to Book (P/B)2.54
Price to Sales (P/S)1.78
P/FCF Ratio14.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.20Price Target Upside32.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.86
Revenue Forecast (FY)€612.29M
Bulls Say, Bears Say
Bulls Say
Improving ProfitabilityStronger gross, operating, and net margins indicate improved efficiency and earnings quality. The rise in operating margin from roughly 8–9% to 13.6% provides greater resilience, supports reinvestment, and can help sustain profitability across the next several quarters.
Reduced LeverageThe substantial reduction in debt relative to equity reflects a healthier capital structure and lower balance-sheet risk. Reduced leverage should improve financial flexibility, lessen refinancing pressure, and leave more capacity to fund operations or strategic growth.
Supportive Cash GenerationStrong operating and free cash flow provide internal funding for capital needs, debt reduction, and ongoing investment in the accessibility and patient-care businesses. Free cash flow also tracks net income reasonably well, supporting the durability of reported earnings.
Bears Say
Moderating Revenue GrowthThe slowdown in revenue growth reduces the pace at which Savaria can expand its earnings base. If accessibility and patient-care demand remains moderate, margin gains may have to carry more of the performance burden, limiting longer-term operating leverage and upside.
Uneven Cash ConversionAlthough cash generation remains positive, declining free cash flow and variable operating cash conversion indicate that reported earnings do not translate into cash at a consistently strong rate. Working-capital or timing variability could constrain deleveraging and investment flexibility.
Meaningful Remaining DebtDeleveraging has materially improved the balance sheet, but the remaining absolute debt still requires sustained margins and cash generation. A weaker operating period could slow further debt reduction and limit the financial flexibility created by recent balance-sheet progress.
Savaria News
S97 FAQ
What was Savaria’s price range in the past 12 months?
Savaria lowest stock price was €11.90 and its highest was €19.40 in the past 12 months.
What is Savaria’s market cap?
Savaria’s market cap is €1.27B.
When is Savaria’s upcoming earnings report date?
Savaria’s upcoming earnings report date is Nov 11, 2026 which is in 64 days.
How were Savaria’s earnings last quarter?
Savaria released its earnings results on Aug 05, 2026. The company reported €0.218 earnings per share for the quarter, beating the consensus estimate of €0.208 by €0.009.
Is Savaria overvalued?
According to Wall Street analysts Savaria’s price is currently Undervalued.
Does Savaria pay dividends?
Savaria does not currently pay dividends.
What is Savaria’s EPS estimate?
Savaria’s EPS estimate is 0.22.
How many shares outstanding does Savaria have?
Savaria has 72,125,320 shares outstanding.
What happened to Savaria’s price movement after its last earnings report?
Savaria reported an EPS of €0.218 in its last earnings report, beating expectations of €0.208. Following the earnings report the stock price went down -0.544%.
Which hedge fund is a major shareholder of Savaria?
Currently, no hedge funds are holding shares in DE:S97
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Savaria Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€22.20 (32.91% Upside)
€22.20 (32.91% Upside)
Insider Transactions
Sold Shares
Worth C$5.1M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
40.69%
12-Months-Change
Fundamentals
Return on Equity
2.03%
Trailing 12-Months
Asset Growth
2.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Savaria
Established in 1979 and headquartered in Laval, Canada, Savaria Corporation delivers a comprehensive suite of accessibility solutions tailored for the elderly and individuals with physical challenges. Its global reach extends across Canada, the United States, Europe, and various international territories. The company's operations are divided into three core segments. The Accessibility segment handles the design, manufacturing, distribution, and installation of a wide array of products, such as stairlifts for both straight and curved stairs, vertical and inclined platform lifts for wheelchairs in commercial and residential environments, and home and accessibility elevators. Through its Patient Care division, Savaria manufactures and supplies therapeutic support surfaces, pressure management items, medical beds, and other equipment crucial for the safe handling of patients. Lastly, the Adapted Vehicles segment specializes in distributing modified vehicles for personal or commercial use by people with mobility impairments. Savaria's products are made available to end-users via both a dealer network and company-owned stores.
S97 Stock 12 Month Forecast
Average Price Target
€22.20
▲(32.91% Upside)